ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,948.71
0.53%
US Tech 100
20,144.80
0.09%
Dow Jones
43,870.35
1.06%
Brent Oil
74.125
0.26%
Bitcoin
98,036.98
-0.48%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Uniqure Nv (0EE0) Quote

Uniqure Nv

Uniqure Nv (0EE0)

LSE
31.50
0.00
(0.00%)
Closed November 21 11:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
31.50
Bid
0.00
Ask
0.00
Volume
1,369
0.00 Day's Range 0.00
31.50 52 Week Range 31.50
Market Cap
1.507B
Previous Close
31.50
Open
-
Last Trade
1
@
5.8786
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
5,322
Shares Outstanding
47,834,000
Dividend Yield
-
PE Ratio
-0.91
Earnings Per Share (EPS)
-6.45
Revenue
21.9M
Net Profit
-308.48M

About Uniqure Nv

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.uniqure.com
Headquarters
Amsterdam, North Holland, Nld
Founded
-
Uniqure Nv is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0EE0. The last closing price for Uniqure Nv was $31.50. Over the last year, Uniqure Nv shares have traded in a share price range of $ 31.50 to $ 31.50.

Uniqure Nv currently has 47,834,000 shares outstanding. The market capitalization of Uniqure Nv is $1.51 billion. Uniqure Nv has a price to earnings ratio (PE ratio) of -0.91.

Ask ADVFN Intelligence (AI)

0EE0 Latest News

More News

uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy

uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy LEXINGTON, Mass. and AMSTERDAM, Nov. 21...

14 hours ago
UK Regulatory

uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress

uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress ~ Type B meeting scheduled with the FDA in the fourth quarter of 2024 to initiate discussions...

November 05 2024
UK Regulatory

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS LEXINGTON, Mass. and AMSTERDAM, Oct. 15, 2024 (GLOBE NEWSWIRE) -- uniQure N.V...

October 15 2024
UK Regulatory

uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease

uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease LEXINGTON, Mass. and AMSTERDAM, Sept. 23, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a...

September 23 2024
UK Regulatory

uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease

uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease LEXINGTON, Mass. and AMSTERDAM, Aug. 15, 2024 (GLOBE NEWSWIRE) -- uniQure...

August 15 2024
UK Regulatory

uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update

uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update ~ Announced RMAT designation for AMT-130 in Huntington’s disease and positive interim Phase I/II data...

August 01 2024
UK Regulatory

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen ~ uniQure maintains preferential access to industry-leading manufacturing capabilities to support its pipeline of gene...

July 23 2024
UK Regulatory

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease ~ Achieved statistically significant...

July 09 2024
UK Regulatory

uniQure Announces Sale of Commercial Manufacturing Facility to Genezen

uniQure Announces Sale of Commercial Manufacturing Facility to Genezen ~ Proposed divestiture streamlines uniQure’s focus and represents an important milestone in its ongoing effort to...

July 01 2024
UK Regulatory

uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease

uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease ~ Designation based on 24-month interim Phase I/II...

June 03 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10031.531.531.579931.5DE
40031.531.531.5281431.5DE
120031.531.531.5532231.5DE
260031.531.531.51134531.5DE
520031.531.531.5646731.5DE
1560031.531.531.5239831.5DE
2600031.531.531.5153831.5DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FARFerro-alloy Resources Limited
6.70p
(185.11%)
41.69M
VELAVela Technologies Plc
0.0075p
(36.36%)
302.56M
ROCRockpool Acquisitions Plc
2.25p
(28.57%)
150k
RCGHRc365 Holding Plc
1.60p
(28.00%)
3.77M
CASPCaspian Sunrise Plc
3.50p
(25.00%)
11M
NTOGNostra Terra Oil And Gas Company Plc
0.02375p
(-36.67%)
1.16B
CNNCaledonian Trust Plc
35.00p
(-36.36%)
103.57k
PPSProton Motor Power Systems Plc
0.125p
(-30.56%)
7.8M
SLFRSlf Realisation Fund Limited
1.02p
(-27.66%)
471.52k
QUIZQuiz Plc
4.02p
(-23.43%)
24.37k
NTOGNostra Terra Oil And Gas Company Plc
0.02375p
(-36.67%)
1.16B
NTVONativo Resources Plc
0.0023p
(0.00%)
517.78M
TRPTower Resources Plc
0.028p
(1.82%)
466.78M
HAYDHaydale Graphene Industries Plc
0.115p
(0.00%)
424.95M
VELAVela Technologies Plc
0.0075p
(36.36%)
302.56M

Discussion

View Full Feed
newflow newflow 46 seconds ago
Difference between What are the Liquidating Trust Assets? & 2. What are the Trust’s Assets now?
2017 FAQ
https://veritaglobal.net/documents/8817600/8817600170920000000000001.pdf

Subject to certain limited exceptions, the Liquidating Trust Interests are not transferable o
COOP
Golden Cross Golden Cross 1 minute ago
$ILLR Sean Kim boasts an impressive background in social media, entertainment, and commerce making him the perfect choice to lead Triller App into its next chapter of expansion and creativity. With his vast expertise and forward-thinking approach, Sean is poised to steer Triller App toward becoming
ILLR
Longstrongsilver Longstrongsilver 1 minute ago
Except I wouldn’t have made any comment on price. Anyone that can read can see my post was again in reply to another pumpy post by a ceo that shouldn’t be commenting on share price(s).

Anyone not overly emotionally invested somewhere would see the difference between a ceo disingenuo
AZRH
fuagf fuagf 2 minutes ago
Disinformation. Ignorance. Fear. Greed... "How did it really get to this."
Billyjack68 Billyjack68 2 minutes ago
Hey Boston, feeling great. Funny, I'm at just over 62k down, where are those big gd ballers around? Hey tell me something about something about something, great. What I've invested is fine, doesn't cost anyone any more as I only hit the ask...anyone else? BGN is solid, he's put his money
AFFU
BIOChecker4 BIOChecker4 2 minutes ago
No George, you were simply wrong in your prediction. We did not paint the tape today.

It’s cleansing for the soul to occasionally admit to being wrong. You should try it.
AVXL
MRc2 MRc2 3 minutes ago
$ILLR~ GREAT NEW VIDEO ~ Triller is hiring TikTok's former head of product to run its video app, as its other CEO hire falls through
Kenneth Niemeyer and Dan Whateley Nov 21, 2024, 10:09 AM PST

https://www.youtube.com/watch?v=fevbIVpkB38
ILLR
waterchaser waterchaser 3 minutes ago
What time is it in Serbia?
In the US we are winding down.
It appears HIRU is winding down as well.
AI is your friend. Use it because we can’t decipher/understand your other (non-AI) messages.
HIRU
lovethatgreen lovethatgreen 4 minutes ago
The link to ShieldCom was on the first version of the website they put out
MONI
ExtremelyBullishZig ExtremelyBullishZig 4 minutes ago
There was news it was biotech news in general. A gene editing company had a big success and the whole biotech sector moved because of it. The people waiting for Missling"s blunder are holding the stock at these levels. If the blunder happens...5.85 is in the future. If it doesn't happen, $15 is in t
AVXL
rs99 rs99 5 minutes ago
That would kill anything good happening. 99-100 % of the time the stock goes right back to where the split happened and destroys the shareholders. Fact! 
RITE
Welcome2Pinkyland Welcome2Pinkyland 6 minutes ago
Wowza $6.80 hod $$
CHYI
mascale mascale 6 minutes ago
Hiru Corporation reported a remarkable revenue increase from less than $1 million in 2023 to over $11 million in 2024, (per Q3). Operating profits rose significantly to $2.76 million, compared to $112,670 during the same period last year. The Revenues of the newly merged mining assets will be reflec
HIRU
3331 3331 7 minutes ago
BIEL: Flagship product RecoveryRx is now available at every VA hospital nationwide!

https://kellycovemobility.com/rrx/
An American hero gives a fantastic testimonial about Bioelectronics flagship product - RecoveryRX!
https://investorshub.advfn.com/boards/read_msg.aspx?m
just Scottie just Scottie 8 minutes ago
If I didn’t dislike him I’d say he has nice jewelry lol
SFLM
3331 3331 8 minutes ago
BIEL: Flagship product RecoveryRx is now available at every VA hospital nationwide!
https://kellycovemobility.com/rrx/
An American hero gives a fantastic testimonial about Bioelectronics flagship product - RecoveryRX!
https://investorshub.advfn.com/boards/read_msg.aspx?message_
just Scottie just Scottie 9 minutes ago
Click on the Mavin site on the X page
https://x.com/sflmaven
SFLM
microcapbiotech microcapbiotech 9 minutes ago
That definition is obvious and simple for even the most simple to comprehend. Bad data is the kind of data that gets trials CANCELED like the AML trials were.
MRKR
VOIP20 VOIP20 9 minutes ago
We joked about the picture of "empty" boxes sent to Sri Lanka. Well with 117K of revenue for the year to date (quarterly report) I don't think we were too far off. There just couldn't have been much value in those boxes. And what about follow-up contracts? Another VPER disappointment. As of report,
VPER
3331 3331 10 minutes ago
RecoveryRx is now available at every VA hospital nationwide!
BIEL
Buckey Buckey 10 minutes ago
SKK closed at 1.50 AH setting 1.89 sell for pm. Thats $590 profit less 10each side fees. The brokerage that trade is in doesn't trade as early or as late AH. Not sure if its 6 am. There is trading before I can execute trades might even be 7 am.
rocketeer357 rocketeer357 11 minutes ago
Shocker news just in: Ohtani and Judge win the MVP awards in their leagues, the final announcement in what could be the most boring, clear-cut awards season ever.

FA sweepstakes and a few trades is all that's left between now and spring training.
gawti88 gawti88 11 minutes ago
Big volume day tomorrow this will run hard.
CEOS

Your Recent History

LSE
0EE0
Uniqure Nv
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved